Revenue
attach_money0M USD
-
NGENNervGen Pharma Corp. Common stock$ --
NervGen Pharma Corp. Common stock
NGEN
$ -
-
Review earnings summary, surprise history, and upcoming forecasts.
analyticsEarnings Summary
FY2025 Q3Updated: 09/30/2025
Operating Income
trending_up-4M USD
-
Net Income
verified-3M USD
-
EPS
paid-0.04$
-
Revenue
$0
NO FORECAST
Q1
Q2
Q3
Cumulative
Estimate (Forecast)Actual (Actual)
FY2025 Q3 YoY
- $-
Net Income
$-3M
MISS
$-2.7M
$-6.7M
$-4.5M
$-3M
$-4.5M
$-12.4M
Estimate (Forecast)Actual (Actual)
FY2025 Q3 YoY
- $-
Surprise History
ActualEstimate
FY2024IN-LINE